Pharmafile Logo
Pharmafocus logo
Advanced Search

EMA expands label for UCB’s Cimzia in axial spondyloarthritis

August 5, 2020
Research and Development, Sales and Marketing Cimzia, EMA, Europe

The European Medicines Agency has expanded the existing approval of UCB’s Cimzia (certolizumab pegol) to cover the treatment of axial …

News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

August 5, 2020
Research and Development COVID-19, Weekly round up, coronavirus

The coronavirus news this week is dominated by vaccine development, as the UK Government sealed another deal to procure an …

News
coca-cola_bottles_for_thai_market_1

Researchers find Coca-Cola paid scientists to downplay how their drinks fuelled the obesity crisis

August 5, 2020
Research and Development, Sales and Marketing Coca-Cola, Coke

Researchers have found that Coca-Cola paid an organization of scientists to downplay how the sugary drinks they sell fuelled the …

News
chrissy

Medipharma appoints Former President of Janssen Chris Halyk to its Board of Directors

August 4, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Medipharma has appointed Chris Halyk, the former President of Janssen, to its Board of Directors. This is the third appointment …

Appointment
enoch_kariuki

VelosBio reveals new Chief Financial Officer

August 4, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing VelosBio, appointment

Dr Enoch Kariuki has been named as the new Chief Financial Officer at biopharma firm VelosBio, where he will assume …

Appointment
duma

Russia claims it will start mass immunisation with a COVID-19 vaccine from October

August 4, 2020
Manufacturing and Production Russia, Vaccine, putin

The Russian government is claiming it will start production of a viable coronavirus vaccine candidate next month and begin the …

News
sanofi_hq

Sanofi indicted on manslaughter charges over its epilepsy drug Depakine

August 4, 2020
Manufacturing and Production Sanofi, Vaccine

Sanofi is being investigated for manslaughter in France over the deaths of four babies whose mothers took its anti-epilepsy medication …

News
uk_gobtg

UK Government tells medicine suppliers to stockpile drugs for no-deal Brexit despite coronavirus concerns

August 4, 2020
Manufacturing and Production UK, brexit, coronavirus

The British government has contacted medicine suppliers urging them to stockpile drugs for a possible no-deal Brexit, despite the pressure …

News
kymriah

Novartis’ CAR T therapy Kymriah nails main goal in follicular lymphoma

August 4, 2020
Manufacturing and Production, Research and Development CAR-T therapy, Cancer, Kymriah, Novartis, car t therapy

Novartis is celebrating the success of its one-time CAR T therapy Kymriah (tisagenlecleucel) in patients with relapsed or refractory (r/r) …

News
janssen_latest_logo_on_sign

FDA expands approval for Janssen’s Spravato nasal spray to cover major depressive disorder with suicidal ideation

August 4, 2020
Manufacturing and Production FDA Janssen, Spravato, depression

The FDA has moved to expand the existing approval of Janssen’s Spravato (esketamine) CIII nasal spray to include treatment of symptoms …

News
1

CAR T cell therapy is revolutionising cancer treatment, but at what cost?

August 3, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, feature

CAR T cell therapy is one of the latest innovations in gene therapy. The process is primarily used to treat …

Feature
novartis_outside_1

Novartis’ Cosentyx gets European go-ahead in paediatric plaque psoriasis

August 3, 2020
Sales and Marketing Cosentyx, Europe, Novartis, pharma, psoriasis

Novartis’ interleukin-17A (IL-17A) inhibitor Cosentyx (secukinumab) has chalked up approval from the European Commission (EC) for the treatment of patients …

News
eu_flag

EU agrees deal with Sanofi for COVID-19 vaccine supply

August 3, 2020
Sales and Marketing COVID, COVID-19, coronavirus

The EU has reached an agreement with Sanofi for 300 million doses of their COVID-19 vaccine candidate which will allow …

News
covid_test

England to start using two new 90-minute COVID-19 tests in preparation for the winter

August 3, 2020
Sales and Marketing COVID-19, coronavirus

Two new coronavirus tests are set to be made available throughout England that are significantly faster than most already in …

News
fdaoutsideweb

FDA gives nod for Monjuvi combo for second-line relapsed or refractory diffuse large B-cell lymphoma

August 3, 2020
Sales and Marketing FDA, Incyte, Monjuvi, morphosys, pharma

The FDA has awarded MorphoSys and Incyte US approval for their Fc-modified cytolytic CD19-targeting monoclonal antibody Monjuvi (tafasitamab-cxix), when used …

News
cbd

FDA approves CBD treatment for seizures associated with tuberous sclerosis complex

August 3, 2020
Sales and Marketing CBD, tsc

The FDA has approved Epidiolex (cannabidiol) as a treatment for seizures associated with tuberous sclerosis complex (TSC) in patients over …

News
shutterstock_138095450

US Government commits $2.1bn to GSK and Sanofi’s COVID-19 vaccine candidate

July 31, 2020
Medical Communications, Research and Development COVID-19, GSK, Sanofi, US, Vaccine

The US Government has announced additional funding into Sanofi and GlaxSmithKline’s efforts to develop a recombinant protein-based vaccine to the …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

July 31, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Roche, UK government, Vaccine, lilly, pharma, top 10

Another week dominated by COVID-19. Among our most popular stories this week, Celltrion’s infliximab biosimilar Remsima has scored approval for …

News
shutterstock_2

Japan reserves 120m doses of BioNTech’s COVID-19 vaccine

July 31, 2020
Manufacturing and Production, Medical Communications BioNTech, COVID-19, Japan, Vaccine, pharma

Japan’s Ministry of Health, Labour and Welfare (MHLW) has sealed a deal with Pfizer and BioNTech to secure 120 million …

News
janssen_latest_logo_on_sign

FDA expands Stelara indication to cover paediatric plaque psoriasis

July 31, 2020
Medical Communications, Sales and Marketing Janssen, Stelara, pharma, plaque psoriasis

Janssen’s IL-12 and IL-23 inhibitor Stelara (ustekinumab) has had its approved indications expanded by the FDA to include the treatment …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026